scholarly journals Role of the Thyroid Gland in Expression of the Thyroid Phenotype of Sbp2-Deficient Mice

Endocrinology ◽  
2019 ◽  
Vol 161 (5) ◽  
Author(s):  
Haruki Fujisawa ◽  
Manassawee Korwutthikulrangsri ◽  
Jiao Fu ◽  
Xiao-Hui Liao ◽  
Alexandra M Dumitrescu

Abstract Selenocysteine insertion sequence-binding protein 2, SBP2 (SECISBP2), is required for selenoprotein synthesis. Partial SBP2 deficiency syndrome manifests characteristic thyroid function tests. The Sbp2 deficiency mouse model, Sbp2 inducible conditional knockout (iCKO), replicates this thyroid phenotype and was used for pathophysiologic investigations. As selenoproteins have an antioxidative role in thyroid gland function, their deficiencies have potential to affect thyroid hormone (TH) synthesis. Sbp2 iCKO mice had larger thyroids relative to body weight and increased thyroidal thyroxine (T4) and triiodothyronine (T3) content while 5' deiodinases enzymatic activities were decreased. Possible mechanisms for the discrepancy between the increased thyroidal T3 and normal circulating T3 were investigated in dynamic experiments. Treatment with bovine thyroid-stimulating hormone (TSH) resulted in increased delta T4 in Sbp2 iCKO mice, indicating increased availability of preformed thyroidal TH. Next, the recovery of TH levels was evaluated after withdrawal of chemical suppression. At one day, Sbp2 iCKO mice had higher serum and thyroidal T3 concomitant with lower TSH, confirming increased capacity of TH synthesis in Sbp2 deficiency. Decreased TH secretion was ruled out as serum and thyroidal TH were high in Sbp2 iCKO mice. Treatment with a low-iodine diet also ruled out thyroidal secretion defect as both serum levels and thyroidal TH content similarly declined over time in Sbp2-deficient mice compared to wild-type (Wt) mice. This study provides evidence for unsuspected changes in the thyroid gland that contribute to the thyroid phenotype of Sbp2 deficiency, with increased thyroidal T4 and T3 content in the setting of increased TH synthesis capacity contributing to the circulating TH levels while thyroidal secretion is preserved.

Author(s):  
E. A. Gusakova ◽  
I. V. Gorodetskaya

The injection of exogenous analogues of glucocorticoid hormones (cortisone, hydrocortisone, corticosterone, dexamethasone, betamethasone, etc.) leads to a change in thyroid function at all levels (biosynthesis and secretion of hormones by the thyroid gland, the transport, interaction with receptors in target organs, biological action, their metabolism and excretion). Glucocorticoid hormones change regulationof the thyroid function: transhypophysially (glucocorticoids block the secretion of thyroliberin, thyroid stimulating hormone, corticotropin releasing hormone, somatoliberin and the production of somatotropin under the influence of the last one) and parahypophysially (glucocorticoids stimulate formation of insulin in β-cells of the pancreas).


Author(s):  
Amal A Sulaiman ◽  
Noori M Luaibi ◽  
Hiba A Qassim

Objective: Due to their unique properties, silver nanoparticles (AgNPs) gained a broad utilization in nano-based industries and medicine, which may expose human to increased levels of NPs. However, little is known about their potential harmful effects on endocrine physiology. Hence, this study aimed to investigate the potential dose- and time-dependent outcomes of AgNPs on serum levels of thyroid hormones and thyroid gland histology in female rats.Methods: A total of 60 female rats were divided into three groups (each of 20 animals), treated with AgNPs for (10, 20, and 30) days. Within each treatment period, animals were assigned into four subgroups each of five rats; control treated with vehicle and the others treated with 12.5, 25, and 50 mg/kg of AgNPs, respectively, by intraperitoneal injection. At the end of treatments, all rats were sacrificed; blood samples were obtained and analyzed for serum levels of T3, T4, and thyroid-stimulating hormone (TSH). Thyroid gland was removed and weighed then kept in buffered formalin solution for microscopic examination.Results: The data showed a significant increase in the weight of the thyroid gland after 20 and 30 days of the treatment with 50 mg/kg of AgNPs, while the 25 mg/kg dose of AgNps resulted in significant increase only after 30 days. Serum levels of T3 and TSH were nonsignificantly altered by AgNPs in all the treatment groups. Thyroxin levels (T4) were significantly decreased after long-term exposure. Histological specimens of AgNPs treated group showed disturbance of the normal architecture of the thyroid tissue with degeneration of thyroid follicles and desquamated luminal cells.Conclusion: The results of the current study suggested the possible disrupting potential of long-term exposure to high level of AgNPs on thyroid gland function and histology in female rats.


2020 ◽  
Vol 51 (3) ◽  
pp. 924-929
Author(s):  
Al-Sa'ady & Hilal

This study was aimed to determine the role of vitamin D on renal function and thyroid gland. Eighty blood samples were collected (20 patients and 20 healthy) of different sex with different ages (28-88) years from Baghdad's hospitals to study the renal function, as well as samples from (20 patients and 20 healthy) of different sex with various ages (12-62) years were collected to study the thyroid gland function. The blood samples of kidney were tested for urea, creatinine and vitamin D, whereas other samples tested for Thyroid stimulating hormone (TSH), Thyroxine (T4), and Tri-iodothyronine (T3), and vitamin D. The results were shown that 70.4% from renal patients have vitamin D deficiency, whereas 29.6% of a healthy individual also suffering from vitamin D difficult. Furthermore, the relative risk (RR) was 9.15 of cohort renal patient. On the other hand, there were weak correlation between gender and age with vitamin D level. Also, the results reveal that 84.6 % of patient with thyroid were suffering from vitamin D deficient and 15.4 % of healthy individual also suffering from vitamin D deficient, therefor the relative risk (RR) was 2.54 of cohort thyroid patient. And there were no significant relationship between gender, age with vitamin D level in patient with thyroid.


2012 ◽  
Vol 81 (2) ◽  
pp. 183-188 ◽  
Author(s):  
Mária Fialkovičová ◽  
Silvia Mardzinová ◽  
Marta Benková ◽  
Jana Mojžišová ◽  
Monika Gaálová ◽  
...  

The aim of our study was to evaluate the influence of seasonal ambient temperature on the thyroid gland function in terms of serum total thyroxine (TT4), free thyroxine (fT4), total triiodothyronine (TT3), and canine thyroid stimulating hormone (cTSH) concentrations in healthy dogs of various breeds living outdoors and to compare them with those living indoors in flats and houses. The monitoring was conducted for 5 years and our study included 162 indoor dogs and 148 outdoor dogs of both sexes from 2 to 12 years of age, categorised into 3 groups according to their body weight: large (n = 17), medium (n = 16) and small (n = 17) breeds. Comparison of the seasonal serum TT4 and fT4 concentrations in both the indoor and outdoor dogs confirmed their fluctuation in relation to the ambient temperature in all weight groups with the lowest average of TT4 and fT4 concentrations recorded in summer and the highest ones in winter. In dogs kept outdoors, the fluctuation of hormone values was significant (P < 0.05). Seasonal serum cTSH fluctuation was found to be significant (P < 0.05) only in the medium breeds living outdoors, but their concentrations did not exceed the reference ranges. The 5-year monitoring of serum TT3 in indoor and outdoor dogs of large, medium, and small breeds clearly showed that its concentrations were not influenced by varying ambient temperature. The study provides for the first time evidence that serum TT4 and fT4 concentrations in dogs kept outdoors directly depend on ambient temperature. This correlation was also expressed by mathematical equations.


Author(s):  
Sophie A Clarke ◽  
Maria Phylactou ◽  
Bijal Patel ◽  
Edouard G Mills ◽  
Beatrice Muzi ◽  
...  

Abstract Context The COVID-19 pandemic continues to exert an immense burden on global health services. Moreover, up to 63% of patients experience persistent symptoms, including fatigue, after acute illness. Endocrine systems are vulnerable to the effects of COVID-19 as many glands express the ACE2 receptor, used by the SARS-CoV-2 virion for cellular access. However, the effects of COVID-19 on adrenal and thyroid gland function after acute COVID-19 remain unknown. Objectives Our objectives were to evaluate adrenal and thyroid gland function in COVID-19 survivors. Design A prospective, observational study was undertaken. Setting Clinical Research Facility, Imperial College NHS Healthcare Trust. Participants Seventy patients ≥ 18 years at least 3 months after diagnosis of COVID-19 were included. Intervention Participants attended a research study visit (08:00-09:30), during which a short Synacthen test (250 µg IV bolus), and thyroid function assessments were performed. Results All patients had a peak cortisol ≥450 nmol/l after Synacthen, consistent with adequate adrenal reserve. Basal and peak serum cortisol did not differ according to disease severity or history of dexamethasone treatment during COVID-19. There was no difference in baseline or peak cortisol after Synacthen or in thyroid function tests, or thyroid status, in patients with fatigue (n=44) compared to those without (n=26). Conclusions Adrenal and thyroid function ≥3 months after presentation with COVID-19 was preserved. Whilst a significant proportion of patients experienced persistent fatigue, their symptoms were not accounted for by alterations in adrenal or thyroid function. These findings have important implications for the clinical care of patients after COVID-19.


Development ◽  
1966 ◽  
Vol 15 (3) ◽  
pp. 281-289
Author(s):  
Allan R. Beaudoin ◽  
James M. Roberts

The role that the thyroid gland may play in embryonic development has been under investigation for many years. A direct relationship between thyroid gland function and development is best illustrated in the amphibia (see Kollros, 1961, for pertinent literature). Attempts to demonstrate a similar influence of thyroxin on development in mammals has led to controversial results, in part due to the difficulty of separating the metabolic from the possible developmental effects of the hormone. In order for thyroxin to exert a direct effect upon the mammalian embryo it must cross the placenta. The bulk of the evidence seems to favor the viewpoint that the placenta is rather impermeable to thyroxin during the early stages of gestation and that this permeability increases near term. This is apparently true of the rabbit and man (Osorio & Myant, 1960) and the rat (Hamburgh, Sobel, Koblin & Rinestone, 1962; Roy & Kobayashi, 1962).


2000 ◽  
Vol 83 (5) ◽  
pp. 3101-3112 ◽  
Author(s):  
Marlies Knipper ◽  
Christoph Zinn ◽  
Hannes Maier ◽  
Mark Praetorius ◽  
Karin Rohbock ◽  
...  

Both a genetic or acquired neonatal thyroid hormone (TH) deficiency may result in a profound mental disability that is often accompanied by deafness. The existence of various TH-sensitive periods during inner ear development and general success of delayed, corrective TH treatment was investigated by treating pregnant and lactating rats with the goitrogen methimazole (MMI). We observed that for the establishment of normal hearing ability, maternal TH, before fetal thyroid gland function on estrus days 17–18, is obviously not required. Within a crucial time between the onset of fetal thyroid gland function and the onset of hearing at postnatal day 12 ( P12), any postponement in the rise of TH-plasma levels, as can be brought about by treating lactating mothers with MMI, leads to permanent hearing defects of the adult offspring. The severity of hearing defects that were measured in 3- to 9-mo-old offspring could be increased with each additional day of TH deficiency during this critical period. Unexpectedly, the active cochlear process, assayed by distortion product otoacoustic emissions (DPOAE) measurements, and speed of auditory brain stem responses, which both until now were not thought to be controlled by TH, proved to be TH-dependent processes that were damaged by a delay of TH supply within this critical time. In contrast, no significant differences in the gross morphology and innervation of the organ of Corti or myelin gene expression in the auditory system, detected as myelin basic protein (MBP) and proteolipid protein (PLP) mRNA using Northern blot approach, were observed when TH supply was delayed for few days. These classical TH-dependent processes, however, were damaged when TH supply was delayed for several weeks. These surprising results may suggest the existence of different TH-dependent processes in the auditory system: those that respond to corrective TH supply (e.g., innervation and morphogenesis of the organ of Corti) and those that do not, but require T3 activity during a very tight time window (e.g., active cochlear process, central processes).


Sign in / Sign up

Export Citation Format

Share Document